Testing a single infusion of an investigational drug in healthy adults
This study tests a new investigational medicine called SSS67, given as a one-time IV infusion. It is an early-phase trial in healthy volunteers to check how safe the drug is and how the body handles it, and it may help researchers decide if it can be developed for future conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- Your weight must be at least 110 pounds (50 kg) for men or 99 pounds (45 kg) for women, and your body mass index (BMI) must be between 18.5 and 32.
- You need to be in generally good health, with normal results from heart, lung, and abdominal exams, and no serious medical conditions.
- You must not be currently doing regular weightlifting or strength training to build muscle.
- You must agree to use highly effective birth control (if you could become pregnant or father a child) and not donate sperm or eggs for 6 months after the dose.
- You must not have taken certain medications, supplements, or herbal products within the past 4 weeks (some exceptions possible).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This study is for healthy men to see how a new experimental drug moves through the body and leaves it. The drug contains a tiny amount of radiation, which helps researchers track it safely.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.